Allan Prochazka
Concepts (327)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Smoking Cessation | 11 | 2023 | 441 | 1.810 |
Why?
| | Preventive Health Services | 5 | 2020 | 153 | 0.900 |
Why?
| | Informed Consent | 6 | 2022 | 199 | 0.890 |
Why?
| | Internal Medicine | 7 | 2016 | 279 | 0.880 |
Why?
| | Diagnostic Tests, Routine | 3 | 2014 | 107 | 0.790 |
Why?
| | Disease | 2 | 2013 | 96 | 0.730 |
Why?
| | Health Status Indicators | 2 | 2013 | 167 | 0.730 |
Why?
| | Early Diagnosis | 2 | 2013 | 251 | 0.710 |
Why?
| | Hospitalists | 3 | 2013 | 267 | 0.680 |
Why?
| | Physical Examination | 3 | 2015 | 244 | 0.650 |
Why?
| | Cancer Survivors | 5 | 2025 | 338 | 0.650 |
Why?
| | Down Syndrome | 3 | 2021 | 525 | 0.600 |
Why?
| | Stress Disorders, Post-Traumatic | 3 | 2016 | 890 | 0.530 |
Why?
| | Motivational Interviewing | 3 | 2016 | 121 | 0.510 |
Why?
| | Weight Reduction Programs | 2 | 2016 | 140 | 0.500 |
Why?
| | Varenicline | 1 | 2016 | 28 | 0.470 |
Why?
| | Anticoagulants | 3 | 2007 | 748 | 0.460 |
Why?
| | Quality of Health Care | 4 | 2018 | 693 | 0.450 |
Why?
| | Comprehension | 3 | 2014 | 187 | 0.450 |
Why?
| | Internship and Residency | 5 | 2016 | 1269 | 0.450 |
Why?
| | Nicotinic Agonists | 1 | 2016 | 135 | 0.430 |
Why?
| | Patient Readmission | 4 | 2015 | 772 | 0.430 |
Why?
| | Veterans | 8 | 2023 | 1642 | 0.420 |
Why?
| | Patient Satisfaction | 3 | 2015 | 712 | 0.400 |
Why?
| | Telemedicine | 3 | 2023 | 966 | 0.390 |
Why?
| | Educational Measurement | 1 | 2016 | 326 | 0.390 |
Why?
| | Telenursing | 1 | 2013 | 10 | 0.380 |
Why?
| | Warfarin | 2 | 2005 | 179 | 0.380 |
Why?
| | Combat Disorders | 1 | 2013 | 42 | 0.380 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 172 | 0.370 |
Why?
| | Acute Coronary Syndrome | 1 | 2016 | 297 | 0.370 |
Why?
| | Students, Medical | 2 | 2016 | 378 | 0.360 |
Why?
| | Iraq War, 2003-2011 | 1 | 2013 | 171 | 0.360 |
Why?
| | Afghan Campaign 2001- | 1 | 2013 | 193 | 0.350 |
Why?
| | Gastric Bypass | 1 | 2013 | 126 | 0.350 |
Why?
| | Hospitalization | 4 | 2016 | 2460 | 0.350 |
Why?
| | Bibliometrics | 1 | 2012 | 66 | 0.340 |
Why?
| | Ambulatory Care Facilities | 1 | 2013 | 269 | 0.330 |
Why?
| | Preoperative Care | 1 | 2014 | 380 | 0.330 |
Why?
| | Patient Discharge | 3 | 2015 | 995 | 0.330 |
Why?
| | Depression | 4 | 2026 | 1557 | 0.330 |
Why?
| | Clinical Trials as Topic | 2 | 2016 | 1062 | 0.320 |
Why?
| | Humans | 66 | 2026 | 145763 | 0.320 |
Why?
| | Publishing | 1 | 2012 | 114 | 0.320 |
Why?
| | Overweight | 1 | 2015 | 614 | 0.310 |
Why?
| | Adult | 28 | 2026 | 40872 | 0.300 |
Why?
| | Tobacco Use Disorder | 3 | 2023 | 217 | 0.300 |
Why?
| | Primary Health Care | 3 | 2015 | 1737 | 0.300 |
Why?
| | Obesity, Morbid | 1 | 2013 | 293 | 0.290 |
Why?
| | Weight Loss | 1 | 2015 | 859 | 0.290 |
Why?
| | Lung Neoplasms | 4 | 2023 | 2667 | 0.280 |
Why?
| | Ethics, Medical | 2 | 2012 | 91 | 0.280 |
Why?
| | Smoking | 4 | 2017 | 1477 | 0.280 |
Why?
| | United States | 18 | 2021 | 16123 | 0.280 |
Why?
| | Publications | 1 | 2008 | 47 | 0.270 |
Why?
| | Aged | 20 | 2023 | 26215 | 0.260 |
Why?
| | Attitude of Health Personnel | 4 | 2016 | 1197 | 0.260 |
Why?
| | Ofloxacin | 2 | 2005 | 17 | 0.250 |
Why?
| | Levofloxacin | 2 | 2005 | 21 | 0.250 |
Why?
| | International Normalized Ratio | 2 | 2005 | 55 | 0.250 |
Why?
| | Research Design | 2 | 2020 | 1139 | 0.250 |
Why?
| | Vena Cava Filters | 1 | 2007 | 64 | 0.250 |
Why?
| | Physicians | 5 | 2016 | 956 | 0.250 |
Why?
| | Physician-Patient Relations | 5 | 2015 | 588 | 0.250 |
Why?
| | Rheumatology | 1 | 2008 | 133 | 0.240 |
Why?
| | Personnel Staffing and Scheduling | 2 | 2010 | 98 | 0.240 |
Why?
| | Quality of Life | 6 | 2026 | 3210 | 0.240 |
Why?
| | Middle Aged | 23 | 2026 | 36302 | 0.240 |
Why?
| | Rehabilitation Centers | 2 | 2015 | 39 | 0.220 |
Why?
| | Pulmonary Embolism | 1 | 2007 | 241 | 0.220 |
Why?
| | Male | 30 | 2026 | 73003 | 0.220 |
Why?
| | Nortriptyline | 1 | 2004 | 9 | 0.220 |
Why?
| | Physicians, Family | 2 | 2009 | 177 | 0.220 |
Why?
| | Obesity | 2 | 2016 | 3118 | 0.220 |
Why?
| | Female | 31 | 2026 | 79035 | 0.210 |
Why?
| | Medical Staff, Hospital | 2 | 2016 | 80 | 0.210 |
Why?
| | Resilience, Psychological | 1 | 2026 | 150 | 0.200 |
Why?
| | Communication | 5 | 2014 | 977 | 0.200 |
Why?
| | Teaching Rounds | 2 | 2016 | 74 | 0.200 |
Why?
| | Biomarkers | 2 | 2022 | 4302 | 0.200 |
Why?
| | Insurance, Health, Reimbursement | 2 | 2015 | 98 | 0.190 |
Why?
| | Burnout, Professional | 2 | 2010 | 488 | 0.190 |
Why?
| | Anti-Infective Agents | 1 | 2005 | 232 | 0.180 |
Why?
| | Confidence Intervals | 3 | 2021 | 330 | 0.180 |
Why?
| | Telerehabilitation | 1 | 2023 | 49 | 0.180 |
Why?
| | Spinal Cord Injuries | 1 | 2026 | 235 | 0.180 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2004 | 185 | 0.180 |
Why?
| | Surveys and Questionnaires | 12 | 2021 | 6085 | 0.180 |
Why?
| | Sleep Initiation and Maintenance Disorders | 1 | 2025 | 196 | 0.180 |
Why?
| | Deafness | 1 | 2023 | 78 | 0.180 |
Why?
| | Nicotine | 1 | 2004 | 331 | 0.180 |
Why?
| | Follow-Up Studies | 6 | 2018 | 5428 | 0.170 |
Why?
| | Hearing Aids | 1 | 2023 | 98 | 0.170 |
Why?
| | Leisure Activities | 1 | 2021 | 31 | 0.160 |
Why?
| | Smoking Prevention | 2 | 2017 | 166 | 0.160 |
Why?
| | Time Factors | 9 | 2021 | 7133 | 0.160 |
Why?
| | Neoplasms | 3 | 2025 | 2913 | 0.160 |
Why?
| | Cohort Studies | 5 | 2018 | 6032 | 0.160 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2008 | 1420 | 0.150 |
Why?
| | Hearing Loss | 1 | 2023 | 249 | 0.150 |
Why?
| | Retrospective Studies | 7 | 2020 | 17325 | 0.140 |
Why?
| | Cross-Sectional Studies | 8 | 2026 | 5922 | 0.140 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 428 | 0.130 |
Why?
| | Odds Ratio | 2 | 2012 | 1083 | 0.120 |
Why?
| | Logistic Models | 4 | 2021 | 2139 | 0.120 |
Why?
| | Interdisciplinary Studies | 1 | 2016 | 30 | 0.120 |
Why?
| | Financing, Organized | 1 | 2016 | 36 | 0.120 |
Why?
| | Evidence-Based Medicine | 3 | 2016 | 740 | 0.120 |
Why?
| | Medicaid | 1 | 2020 | 467 | 0.120 |
Why?
| | Prenatal Care | 1 | 2018 | 309 | 0.120 |
Why?
| | Delivery of Health Care | 2 | 2020 | 947 | 0.110 |
Why?
| | Contraindications | 1 | 2015 | 90 | 0.110 |
Why?
| | Clinical Competence | 2 | 2014 | 1247 | 0.110 |
Why?
| | Preventive Medicine | 1 | 2015 | 39 | 0.110 |
Why?
| | Learning | 2 | 2016 | 444 | 0.110 |
Why?
| | Decision Support Systems, Management | 1 | 2015 | 7 | 0.110 |
Why?
| | Surgeons | 1 | 2020 | 340 | 0.110 |
Why?
| | Disclosure | 2 | 2012 | 84 | 0.110 |
Why?
| | Patient Care | 1 | 2016 | 120 | 0.110 |
Why?
| | Risk Assessment | 4 | 2015 | 3752 | 0.110 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2018 | 269 | 0.100 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2025 | 1751 | 0.100 |
Why?
| | Pilot Projects | 3 | 2023 | 1897 | 0.100 |
Why?
| | Teaching | 1 | 2016 | 237 | 0.100 |
Why?
| | United States Department of Veterans Affairs | 1 | 2018 | 779 | 0.100 |
Why?
| | Treatment Outcome | 7 | 2025 | 11793 | 0.100 |
Why?
| | Substance Abuse Treatment Centers | 1 | 2014 | 49 | 0.100 |
Why?
| | Data Interpretation, Statistical | 2 | 2014 | 368 | 0.100 |
Why?
| | Costs and Cost Analysis | 2 | 2013 | 221 | 0.100 |
Why?
| | Curriculum | 2 | 2013 | 1074 | 0.100 |
Why?
| | Medication Adherence | 1 | 2018 | 540 | 0.100 |
Why?
| | Faculty, Medical | 1 | 2016 | 305 | 0.100 |
Why?
| | Incidental Findings | 1 | 2014 | 81 | 0.100 |
Why?
| | Guidelines as Topic | 2 | 2013 | 268 | 0.100 |
Why?
| | Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2013 | 36 | 0.100 |
Why?
| | Drug Interactions | 2 | 2005 | 405 | 0.090 |
Why?
| | Nursing Homes | 1 | 2015 | 174 | 0.090 |
Why?
| | Patient Transfer | 1 | 2015 | 211 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 2 | 2013 | 2770 | 0.090 |
Why?
| | Inpatients | 2 | 2017 | 553 | 0.090 |
Why?
| | Patient Care Management | 1 | 2013 | 56 | 0.090 |
Why?
| | Research | 1 | 2016 | 431 | 0.090 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2015 | 261 | 0.090 |
Why?
| | Mental Recall | 1 | 2014 | 223 | 0.090 |
Why?
| | Early Medical Intervention | 1 | 2013 | 63 | 0.090 |
Why?
| | Administration, Oral | 2 | 2005 | 867 | 0.090 |
Why?
| | Health Literacy | 1 | 2014 | 186 | 0.090 |
Why?
| | Pharmacists | 1 | 2015 | 258 | 0.090 |
Why?
| | Morbidity | 1 | 2013 | 322 | 0.090 |
Why?
| | Government Regulation | 1 | 2012 | 39 | 0.090 |
Why?
| | Self Care | 1 | 2015 | 392 | 0.090 |
Why?
| | Methotrexate | 1 | 2013 | 233 | 0.090 |
Why?
| | Practice Patterns, Physicians' | 2 | 2015 | 1372 | 0.090 |
Why?
| | Aged, 80 and over | 4 | 2015 | 8346 | 0.090 |
Why?
| | Hospitals, University | 1 | 2012 | 176 | 0.090 |
Why?
| | Perception | 1 | 2014 | 378 | 0.090 |
Why?
| | Risk | 1 | 2014 | 923 | 0.080 |
Why?
| | Nurse's Role | 1 | 2013 | 149 | 0.080 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2012 | 148 | 0.080 |
Why?
| | Adolescent | 5 | 2021 | 22573 | 0.080 |
Why?
| | Drug Therapy, Combination | 2 | 2004 | 1043 | 0.080 |
Why?
| | Primary Prevention | 1 | 2013 | 222 | 0.080 |
Why?
| | Hospital Costs | 1 | 2012 | 125 | 0.080 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 208 | 0.080 |
Why?
| | Chemoembolization, Therapeutic | 1 | 2012 | 89 | 0.080 |
Why?
| | Glucocorticoids | 1 | 2015 | 532 | 0.080 |
Why?
| | Radiography, Interventional | 1 | 2012 | 128 | 0.080 |
Why?
| | Mortality | 1 | 2013 | 380 | 0.080 |
Why?
| | Hospitals | 1 | 2015 | 733 | 0.080 |
Why?
| | Antirheumatic Agents | 1 | 2013 | 307 | 0.080 |
Why?
| | Anti-HIV Agents | 1 | 2018 | 912 | 0.080 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1582 | 0.080 |
Why?
| | Health Services Accessibility | 1 | 2018 | 1101 | 0.080 |
Why?
| | Work Schedule Tolerance | 2 | 2010 | 51 | 0.080 |
Why?
| | Decision Making | 2 | 2014 | 982 | 0.080 |
Why?
| | Information Dissemination | 1 | 2012 | 224 | 0.080 |
Why?
| | Colorado | 5 | 2020 | 4556 | 0.070 |
Why?
| | Health Care Surveys | 2 | 2015 | 536 | 0.070 |
Why?
| | Interviews as Topic | 1 | 2013 | 916 | 0.070 |
Why?
| | Reproducibility of Results | 2 | 2014 | 3416 | 0.070 |
Why?
| | Early Detection of Cancer | 1 | 2014 | 486 | 0.070 |
Why?
| | Exercise | 1 | 2021 | 2205 | 0.070 |
Why?
| | Adaptation, Psychological | 1 | 2014 | 719 | 0.070 |
Why?
| | Databases, Bibliographic | 1 | 2008 | 30 | 0.070 |
Why?
| | Counseling | 3 | 2023 | 401 | 0.070 |
Why?
| | Age Factors | 4 | 2015 | 3346 | 0.070 |
Why?
| | Beneficence | 1 | 2008 | 20 | 0.070 |
Why?
| | Feasibility Studies | 1 | 2013 | 1115 | 0.070 |
Why?
| | Socioeconomic Factors | 3 | 2021 | 1327 | 0.070 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2012 | 373 | 0.070 |
Why?
| | Catheter Ablation | 1 | 2012 | 355 | 0.070 |
Why?
| | Social Justice | 1 | 2008 | 81 | 0.070 |
Why?
| | Job Satisfaction | 2 | 2010 | 238 | 0.060 |
Why?
| | Patient Care Team | 1 | 2013 | 697 | 0.060 |
Why?
| | Surgical Procedures, Operative | 1 | 2010 | 271 | 0.060 |
Why?
| | Alcoholism | 1 | 2014 | 826 | 0.060 |
Why?
| | Gastroenterology | 1 | 2009 | 191 | 0.060 |
Why?
| | Patient Education as Topic | 2 | 2012 | 777 | 0.060 |
Why?
| | Thromboembolism | 1 | 2007 | 129 | 0.060 |
Why?
| | Linear Models | 3 | 2014 | 849 | 0.060 |
Why?
| | Age Distribution | 1 | 2007 | 404 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2015 | 1101 | 0.060 |
Why?
| | Child | 3 | 2020 | 22739 | 0.060 |
Why?
| | Prazosin | 1 | 2005 | 25 | 0.060 |
Why?
| | Colonoscopy | 1 | 2008 | 264 | 0.060 |
Why?
| | Quality Improvement | 1 | 2014 | 1296 | 0.060 |
Why?
| | Lung | 3 | 2023 | 4116 | 0.060 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2005 | 43 | 0.060 |
Why?
| | Liver Neoplasms | 1 | 2012 | 777 | 0.060 |
Why?
| | Biomedical Research | 1 | 2012 | 719 | 0.060 |
Why?
| | Longitudinal Studies | 2 | 2018 | 2967 | 0.050 |
Why?
| | Azithromycin | 1 | 2005 | 101 | 0.050 |
Why?
| | Administration, Cutaneous | 1 | 2004 | 127 | 0.050 |
Why?
| | Myocardial Ischemia | 1 | 2006 | 285 | 0.050 |
Why?
| | Cholesterol, LDL | 1 | 2006 | 360 | 0.050 |
Why?
| | Arthritis, Rheumatoid | 1 | 2013 | 1180 | 0.050 |
Why?
| | Probability | 1 | 2004 | 308 | 0.050 |
Why?
| | Proportional Hazards Models | 1 | 2007 | 1330 | 0.050 |
Why?
| | Reference Values | 1 | 2004 | 798 | 0.050 |
Why?
| | Immunologic Tests | 1 | 2022 | 16 | 0.050 |
Why?
| | Hospitals, Veterans | 2 | 2017 | 258 | 0.050 |
Why?
| | Drug Administration Schedule | 1 | 2004 | 782 | 0.050 |
Why?
| | Tobacco Products | 1 | 2023 | 84 | 0.050 |
Why?
| | Muscles | 1 | 2023 | 330 | 0.050 |
Why?
| | Double-Blind Method | 2 | 2004 | 2064 | 0.050 |
Why?
| | HIV Infections | 1 | 2018 | 3195 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2022 | 163 | 0.040 |
Why?
| | Fluoxetine | 1 | 2002 | 56 | 0.040 |
Why?
| | Public Opinion | 1 | 2002 | 62 | 0.040 |
Why?
| | Health Maintenance Organizations | 1 | 2002 | 105 | 0.040 |
Why?
| | Dyspnea | 1 | 2023 | 250 | 0.040 |
Why?
| | Health Behavior | 1 | 2007 | 791 | 0.040 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2005 | 499 | 0.040 |
Why?
| | Risk Factors | 4 | 2021 | 10917 | 0.040 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2021 | 57 | 0.040 |
Why?
| | Medicare | 2 | 2020 | 904 | 0.040 |
Why?
| | Disease Susceptibility | 1 | 2022 | 344 | 0.040 |
Why?
| | Young Adult | 2 | 2015 | 14251 | 0.040 |
Why?
| | Cardiovascular Diseases | 1 | 2013 | 2191 | 0.040 |
Why?
| | Pennsylvania | 1 | 2020 | 138 | 0.040 |
Why?
| | Michigan | 1 | 2020 | 134 | 0.040 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2028 | 0.040 |
Why?
| | Data Collection | 2 | 2013 | 643 | 0.040 |
Why?
| | Accidental Falls | 1 | 2023 | 230 | 0.040 |
Why?
| | Prospective Studies | 2 | 2018 | 8075 | 0.040 |
Why?
| | Colorectal Neoplasms | 1 | 2008 | 868 | 0.040 |
Why?
| | Oral Health | 1 | 2021 | 139 | 0.040 |
Why?
| | Survivors | 1 | 2023 | 523 | 0.040 |
Why?
| | Continuity of Patient Care | 2 | 2014 | 297 | 0.040 |
Why?
| | Behavior Therapy | 1 | 2002 | 296 | 0.040 |
Why?
| | Blood Pressure | 1 | 2006 | 1782 | 0.040 |
Why?
| | Length of Stay | 2 | 2015 | 1350 | 0.040 |
Why?
| | Attitude to Health | 1 | 2002 | 430 | 0.040 |
Why?
| | Walking | 1 | 2023 | 545 | 0.030 |
Why?
| | Electronic Health Records | 2 | 2017 | 1202 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2010 | 1300 | 0.030 |
Why?
| | Guideline Adherence | 1 | 2002 | 587 | 0.030 |
Why?
| | Community Health Services | 1 | 2018 | 231 | 0.030 |
Why?
| | Formative Feedback | 1 | 2016 | 36 | 0.030 |
Why?
| | Behavior | 1 | 2016 | 90 | 0.030 |
Why?
| | Self Report | 1 | 2021 | 876 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2874 | 0.030 |
Why?
| | Pregnancy Complications | 1 | 2002 | 603 | 0.030 |
Why?
| | Health Status | 1 | 2021 | 835 | 0.030 |
Why?
| | Vulnerable Populations | 1 | 2016 | 176 | 0.030 |
Why?
| | Alcohol Withdrawal Delirium | 1 | 2014 | 9 | 0.030 |
Why?
| | Alaska | 1 | 2014 | 77 | 0.030 |
Why?
| | Mental Health | 1 | 2021 | 796 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2014 | 291 | 0.020 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 883 | 0.020 |
Why?
| | Academic Medical Centers | 1 | 2016 | 554 | 0.020 |
Why?
| | Physician-Nurse Relations | 1 | 2013 | 18 | 0.020 |
Why?
| | Hospitals, Teaching | 1 | 2013 | 121 | 0.020 |
Why?
| | Residence Characteristics | 1 | 2016 | 375 | 0.020 |
Why?
| | Health Services Research | 1 | 2015 | 391 | 0.020 |
Why?
| | Models, Psychological | 1 | 2014 | 294 | 0.020 |
Why?
| | Patient Rights | 1 | 2012 | 11 | 0.020 |
Why?
| | Decision Trees | 1 | 2012 | 78 | 0.020 |
Why?
| | Body Weight | 1 | 2016 | 972 | 0.020 |
Why?
| | Program Evaluation | 1 | 2016 | 944 | 0.020 |
Why?
| | Focus Groups | 1 | 2014 | 572 | 0.020 |
Why?
| | Computer-Assisted Instruction | 1 | 2012 | 70 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2012 | 148 | 0.020 |
Why?
| | Cost Savings | 1 | 2012 | 86 | 0.020 |
Why?
| | Patient-Centered Care | 1 | 2016 | 547 | 0.020 |
Why?
| | Models, Economic | 1 | 2012 | 62 | 0.020 |
Why?
| | Personal Autonomy | 1 | 2012 | 61 | 0.020 |
Why?
| | Radiotherapy | 1 | 2012 | 206 | 0.020 |
Why?
| | Patient Care Planning | 1 | 2012 | 170 | 0.020 |
Why?
| | Motivation | 1 | 2015 | 602 | 0.020 |
Why?
| | Physician's Role | 1 | 2012 | 225 | 0.020 |
Why?
| | Cholecystectomy, Laparoscopic | 1 | 2010 | 55 | 0.020 |
Why?
| | Prostatectomy | 1 | 2010 | 94 | 0.020 |
Why?
| | Documentation | 1 | 2012 | 199 | 0.020 |
Why?
| | Quality Assurance, Health Care | 1 | 2012 | 342 | 0.020 |
Why?
| | Seizures | 1 | 2014 | 485 | 0.020 |
Why?
| | Endarterectomy, Carotid | 1 | 2010 | 64 | 0.020 |
Why?
| | Pregnancy | 2 | 2018 | 7215 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 528 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2110 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2012 | 644 | 0.020 |
Why?
| | Observation | 1 | 2008 | 54 | 0.020 |
Why?
| | Patient Participation | 1 | 2012 | 446 | 0.020 |
Why?
| | Genotype | 1 | 2013 | 1857 | 0.020 |
Why?
| | Educational Status | 1 | 2010 | 470 | 0.020 |
Why?
| | Health Personnel | 1 | 2014 | 757 | 0.020 |
Why?
| | Medicine | 1 | 2009 | 125 | 0.020 |
Why?
| | Arthroplasty, Replacement, Hip | 1 | 2010 | 183 | 0.020 |
Why?
| | Postoperative Care | 1 | 2009 | 286 | 0.020 |
Why?
| | Computer Simulation | 1 | 2012 | 1003 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2012 | 480 | 0.020 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2013 | 2181 | 0.010 |
Why?
| | Emotions | 1 | 2010 | 577 | 0.010 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2933 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2123 | 0.010 |
Why?
| | Registries | 1 | 2013 | 2410 | 0.010 |
Why?
| | Liver Transplantation | 1 | 2009 | 826 | 0.010 |
Why?
| | Multivariate Analysis | 1 | 2006 | 1547 | 0.010 |
Why?
| | Reimbursement Mechanisms | 1 | 2002 | 79 | 0.010 |
Why?
| | Telephone | 1 | 2002 | 177 | 0.010 |
Why?
| | Medical Records | 1 | 2002 | 192 | 0.010 |
Why?
| | Anxiety | 1 | 2008 | 1122 | 0.010 |
Why?
| | Regression Analysis | 1 | 2002 | 1001 | 0.010 |
Why?
| | Obstetrics | 1 | 2002 | 177 | 0.010 |
Why?
| | Mass Screening | 1 | 2008 | 1361 | 0.010 |
Why?
| | Combined Modality Therapy | 1 | 2002 | 1270 | 0.010 |
Why?
| | Health Promotion | 1 | 2002 | 775 | 0.010 |
Why?
|
|
Prochazka's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|